Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (10): 1430-1440.doi: 10.12092/j.issn.1009-2501.2026.10.014

Previous Articles    

Research progress of drugs in the treatment of cerebral ischemia-reperfusion injury through the JNK signaling pathway

Haobo GAO1(), Hifsa Bibi1, Pengcheng ZHU1, Hongtu TAN1, Tao WU2,*()   

  1. 1. Henan University of Traditional Chinese Medicine, Zhengzhou 450046, Henan, China
    2. Department of Interventional Medicine, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450099, Henan, China
  • Received:2025-05-12 Revised:2025-10-26 Online:2026-10-26 Published:2026-11-11
  • Contact: Tao WU E-mail:gaohaobo8128@163.com;wutao@hactcm.edu.cn

Abstract:

After the blood supply of the brain is limited, the secondary tissue injury caused by the reperfusion is called cerebral ischemia-reperfusion injury (CIRI). In this pathological process, the JNK signaling pathway, as a key signal transduction pathway, has a decisive impact on the apoptosis of neurons, the maintenance of cell homeostasis and other physiological activities. The activation of the JNK signaling pathway is closely related to apoptosis, blood-brain barrier destruction and inflammatory response in CIRI. Therefore, this pathway is regarded as a potential target for the treatment of CIRI. This review summarizes recent research progress on the therapeutic effect of drugs on CIRI by regulating the JNK signaling pathway, in order to provide theoretical support and innovative research directions for the treatment of cerebral ischemia-reperfusion injury.

Key words: JNK, CIRI, apoptosis, blood brain barrier, inflammatory reaction

CLC Number: